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abstract
 Background: This study assessed several common oxidative indices in subjects infected with 
intestinal parasites, as well as in colorectal cancer (CRC) patients both with and without intestinal 
parasites.
 Method: Serum levels of malondialdehyde (MDA), ferric reducing/antioxidant power (FRAP), 
and hydrogen peroxide (H2O2) were measured, as were plasma levels of advanced oxidation protein 
products (AOPP), all according to established methods. The presence of intestinal parasites was 
confirmed by stool examination.
 Results: All intestinal parasiteinfected subjects and CRC patients showed the presence of 
oxidative stress. Thirtysix percent of the CRC patients had intestinal parasitic infections. The levels of 
H2O2 and FRAP in parasite-infected subjects were significantly higher than in CRC patients, but these 
levels were significantly lower in the CRC patients with parasitic infections.
 Conclusion: Parasitic infection and CRC may contribute to oxidative stress independently, but 
when present together, the oxidative stress burden imposed by parasites may be attenuated.
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introduction
Protozoan and helminth parasites secrete enzymes 
that generate superoxides and reactive oxygen 
intermediates (such as hydrogen peroxide (H2O2)) 
in mammalian tissues (1). Reactive oxygen species 
(ROS) are produced by the imflammatory cells 
of the host, and these work to kill the invading 
parasites by nitration, oxidation and chlorination 
reactions (2). These reactive species have also 
been implicated as contributing factors in the 
pathophysiology of cancer (3) and various other 
diseases (4,5). Oxidative stress occurs as a result 
of a shift in the balance between the production of 
free radicals and antioxidant defenses (6) in favour 
of free radicals, specifically ROS. ROS such as 
superoxide radicals (O2), hydroxyl radicals (OH
•), 
H2O2 and hydroperoxide can inflict oxidative 
damage on lipids, proteins and nucleic acids (3). 
This can lead to DNA mutations, which in turn are
carcinogenic (7).
 The global prevalence of colorectal cancer 
(CRC) is high, and it accounts for 655,000 deaths 
out of 58 million deaths worldwide in 2005 (8). In 
Malaysia, CRC is the most common cancer among 
men (14.2% of male cancers) and the third most 
common cancer among women (10.1% of female 
cancers) (9). Factors such as age, diet, and genetic 
susceptibility have been suggested to contribute 
to the aetiology of CRC (10), and these risk factors 
may exert their effects through prolonged oxidative
stress (3). Pathological records and analyses have 
shown hostand organ dependent correlations 
between numerous types of cancers and parasitic 
infections (11,12). However, assessments of the 
presence of parasites in CRC patients and their 
effect on oxidative stress are still lacking.
 Therefore, in this study, the levels of various 
oxidative indices in CRC patients and parasite 
infected patients were compared.
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Materials and Methods
Subjects
 A total of 59 patients were recruited from the 
ncology Clinic at the University Malaya Medical 
Centre (UMMC), Kuala Lumpur, Malaysia. All 
the CRC patients were undergoing chemotherapy. 
Twenty-one of these patients were confirmed to 
be infected with one or more intestinal parasites 
by stool examination and were classified as 
CRC patients with parasitic infections. Subjects 
without CRC but positive for parasitic infection 
were recruited among outpatients attending the 
UMMC and patients attending medical camps in 
the Klang Valley, Malaysia. Healthy volunteers 
(controls, n=100) were recruited from the same 
area where the medical camps were held. The study 
was approved by the Medical Ethics committee of 
the UMMC in accordance with the declaration of 
Helsinki.
Sample collection and preparation
 Blood, urine and stool samples were collected 
from all subjects. Blood samples were collected in 
plain tubes and EDTA tubes to obtain serum and 
plasma, respectively. The separated serum and 
plasma were used for the analysis of oxidative 
indices. Urine and stool samples were collected 
in sterile cytology containers. Urinalysis using 
the dipstick method (Combur Test UX, Roche 
Diagnostics) was carried out to test for the levels of 
glucose, bilirubin, nitrite, protein, ketone bodies, 
urobilinogen and blood. Urine samples that 
showed biochemical abnormalities were excluded 
from this study. Parasitological investigation 
was also carried out on all stool samples to 
screen for the following parasites: Entamoeba 
histolytica, Giardia lamblia, Blastocystis hominis, 
Microsporidia sp., Dientamoeba fraglis, Ascaris 
lumbrocoides, Trichuris trichiura, hookworm and 
Taenia sp. Patients that tested positive for one or 
more of these parasites were classified as parasite-
infected subjects.
 
Oxidative indices
 Serum was used for the assessment of lipid 
peroxidation (LP), ferric reducing/antioxidant 
power (FRAP) and H2O2, whereas plasma was 
used for the determination of advanced oxidation 
protein products (AOPP). LP was determined by 
measuring malondialdehyde (MDA) according 
to the modified method of Ratty and Das (12), 
using 1,1,3,3- tetraethoxypropane as a standard. 
The FRAP assay was carried out according to the 
method of Benzie and Strain (13). The reduction of 
ferric tripyridyltriazine (FeIIITPTZ) complex by the
non-enzymatic antioxidants in biological fluids was 
monitored spectrophotometrically using a kinetic 
mode at 593nm. Serum H2O2 was measured using 
the ferrous ion oxidative xylenol orange version-2
(FOX-2) method of Benarjee et al. (14). AOPP was 
measured spectrophotometrically according to the 
method of WitkoSarsat et al. (15).
Parasitological analysis
 Fresh faecal samples were obtained from 
the subjects and preserved in 10% buffered 
formalin for parasitological investigation. 
Intestinal helminths: The formalinethyl acetate 
concentration (FEAc) method (16) was used to 
detect Ascaris lumbrocoides, Trichuris trichuria, 
hookworm and Taenia sp. Intestinal protozoa, 
Dientamoeba fragilis and Giardia lamblia were 
Table 1: Demographic data of the study subjects
Variables Normal
Subject Groups
CRC with parasitic 
infection
CRC without parasitic 
infection
Parasitic infection 
only
n 100 21 38 40
Age 57 ± 12 59 ± 11 57 ± 12 53 ± 15
Gender
Male 43 12 20 26
Female 57 9 18 14
Chemotherapy 
Regimen
Nil Mayo (fluorouracil, 
foliclinic acid) or 
Folfox (Folinic 
acid, Fluorouracil, 
Oxaliplatin)
Mayo (fluorouracil, 
folinic acid) or 
Folfox (Folinic 
acid, Flouroucacil, 
Oxaliplatin)
NA
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screened using the trichrome staining method 
(17), whereas Microsporidia sp. and Blastocystis 
hominis were detected with a modified trichrome 
staining method (18) and a culture technique (19) 
respectively.
Statistical analysis
 Data were analysed with SPSS for Windows 
(Version 13.0). All data are expressed as means 
± SEM, and significant differences between the 
patient and control groups were analysed using 
Student’s t-test. Comparisons of the measured 
parameters among the patient groups were 
analysed using ANOVA.
Results and Discussion
 The demographic data of the CRC patients 
(with and without parasitic infections) and 
the parasite-infected subjects without CRC are 
presented in Table 1. All the cancer patients were 
on chemotherapy, and the one should not rule 
out the possible influence that different anti-
cancer drugs may have on the levels of oxidative 
damage. However, when we made comparisons 
among the cancer patients according to the type of 
chemotherapy they were undergoing, no significant 
differences were observed (results not shown). The 
possibility remains that the different chemotherapy 
protocols affected the oxidative indices, but did so 
similarly.
 Parasite-infected subjects without CRC were 
also found to be positive for multiple parasitic 
infections. Comparisons based on the type and 
multiplicity of the parasitic infection did not show 
significant differences (result not shown), although 
this could have been due to the small sample size. 
Interestingly, 18 CRC patients were positive for
Microsporidia sp., one was positive for Blastocystis
hominis and two were positive for both 
Microsporidia sp. and Blastocystis hominis 
(data not shown). In all, 36% (21/59) of the CRC 
patients tested positive for intestinal parasitic 
infections, and the most common infection was 
Microsporidia sp. an opportunistic parasite. 
Rudrapatna et al. (20) reported that only 16.5 % of 
1029 cancer patients tested positive for intestinal 
parasitic infections. Botero et al. (21) showed 
that in immunocompromised patients, only 9% 
(10/111) had opportunistic parasitic infections 
such as Cryptosporidium sp., Microsporidia sp. 
and Strongyloides stercoralis. Conversely, 42% of 
Malaysian children with cancer were reported to be 
positive for intestinal parasites (22).
 MDA levels, which are used as an indicator of 
oxidative stress in cells and tissues (23), reflect the 
Table 2: Non enzymatic oxidant/antioxidant indices in blood samples: Comparison of normal 
subjects, CRC patients with and without parasitic infections, and subjects with  
arasitic infections only
Sample 
Group
Oxidative indices
n AOPP(µmol/L)
FRAP
(µmol/L)
H2O2
(µmol/L)
MDA
(µmol/L)
Normal 100 128.95±4.91 376.56±8.03 20.78±1.05 0.089±0.007
CRC with 
parasitic 
infection
21 192.41±85.21
**
370.53±80.15 25.07±3.27
**
0.125±0.071
*
CRC 
without 
parasitic 
infection
38 151.95±49.03
*
358.47±78.16 24.53±4.68
**
0.149±0.081
***
Parasitic 
infection 
only
40 198.63±10.74
***
†
625.01±27.84
***
##
† †
41.90±2.26
***
##
† †
0.173±0.013
***
Data are given as mean ± SEM
**P<0.001 * P<0.05, **P<0.01, comparison with controls using Student’s t-test
Comparison among the diseased groups was analysed using ANOVA
##P<0.001 is the comparison between ‘CRC with parasitic infection’ and ‘Parasitic infection only’
†P<0.01, ††P<0.001 is the comparison between ‘CRC without parasitic infection’ and ‘Parasitic infection only’
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overall lipid damage level. Lipid damage is a well-
known mechanism of cellular injury in humans. 
We found that serum MDA levels were higher in 
both CRC patients and parasite-infected subjects 
(P <0.001 for each) than in normal individuals 
(Table 2). Numerous studies have shown that 
MDA levels in both plasma and tumour tissues of 
CRC patients are elevated (24,25). Also, parasitic 
infections, especially intestinal parasites, are 
known to cause cellular damage (26). This could 
lead to the elevated serum MDA levels in patients 
with intestinal parasites such as Giardia sp. (27) 
and Blastocystis hominis (23). However, in the 
present study, the MDA levels among the three 
groups were not significantly different (Table 2).
 Plasma and serum AOPP levels have been 
widely used as markers of free radical induced 
protein damage in renal disease (15,28), diabetic 
complications (29), patients with parasitic 
infections and patients with CRC (30,31). To the 
best of our knowledge, this is the first study that 
reports elevated plasma AOPP levels in CRC 
patients with simultaneous parasitic infections. 
The increased plasma AOPP levels in the CRC 
and parasite-infected patient groups indicate that 
these patients have a higher degree of oxidative 
protein damage than do healthy controls (Table 
2). Similarly, Kosova et al. (32) showed that 
serum AOPP levels were significantly higher in 
thyroid cancer patients than in normal subjects. 
AOPP levels in subjects with parasitic infections 
only were significantly higher than they were 
in CRC patients without parasitic infection (P 
<0.01), but were comparable to CRC patients with 
parasitic infections (Table 2). An in vitro study of 
nematode parasites demonstrated the existence 
of an inflammatory system capable of generating 
hypohalous acids (33) such as HOCl. This could 
explain the enhanced formation of AOPP in the 
subjects infected with parasites.
 H2O2 is an oxidizing agent that can easily be 
converted into OH• when exposed to ultraviolet rays 
or ferrous ions (34). Urinary H2O2 has been used as 
an oxidative stress biomarker in malignancy (14) 
and urinary tract infections (35). The CRC patients 
and the parasite-infected subjects showed higher 
levels of H2O2 than the healthy controls (Table 2). 
Interestingly, the H2O2 levels in parasite-infected 
subjects were almost two-fold higher than in CRC 
patients, but were attenuated in parasite-infected 
subjects with CRC (Table 2). One possibility is that, 
in order to fight parasites, monocytes produce 
O2
• by stimulating xanthine oxidase activity 
(O2
•  is formed when xanthine oxidase converts 
hypoxanthine to xanthine). This excess O2
• is then 
converted to H2O2 by superoxide dismutase (SOD) 
(34). When a parasitic infection is present in CRC 
patients who are on chemotherapy, glutathione 
peroxidase/catalase (H2O2-inactivating enzymes) 
may be induced, leading to a net reduction in 
H2O2 levels. Chemotherapeutic drugs are generally 
cytotoxic, and mononuclear cells have been 
reported to respond to cytotoxicity by increasing 
glutathione peroxidase levels (36).
 FRAP levels are indicative of the total amount 
of non-enzymatic antioxidants. These include lipid-
soluble antioxidants such as vitamin E, vitamin 
A, and provitamin A (beta-carotene); and water-
soluble antioxidants such as vitamin C, uric acid, 
bilirubin and glutathione. We found that FRAP 
levels were lower in CRC patients than in healthy 
subjects (Table 2), possibly due to sequestration 
by tumour cells and/or oxidants released by 
the chemotherapeutic agents. Saygili et al. (24) 
observed reduced plasma vitamin C levels in CRC 
patients. Interestingly, we found that FRAP levels 
in the subjects with parasitic infections only were 
66% higher than in any of other patients groups 
(Table 2). At first glance, this result appears to 
be in conflict with the general notion that under 
oxidative stress, increased macromolecular damage 
is accompanied by a reduction in antioxidant levels 
(37). However, the present findings are supported 
by another  study that demonstrated a significant 
increase in non-enzymatic antioxidants in the 
serum of mice infected with Trichinella spiralis 
(38). This increase in FRAP levels in the parasite-
infected subjects might be caused by an increase 
in serum uric acid due to biochemical changes in 
the body that occur in response to the infection. 
In agreement with this hypothesis, plasma uric 
acid levels were found to be elevated in mice with 
late stage Plasmodium vinckei infections (39). 
Previous studies have reported that increased 
plasma uric acid may account for as much as 60% 
of FRAP activity (13), and uric acid may be the 
main antioxidant in birds (40).
 The reduced FRAP level in CRC patients with 
parasitic infections could be a consequence of 
the regulation of xanthine oxidase (XO) activity. 
When a parasitic infection occurs, XO (the 
dehydrogenase form) converts xanthine (which is 
generated during superoxide radical production 
for parasite eradication) to uric acid (41). Since 
the CRC patients with parasitic infections were 
also on chemotherapy, XO may be inactivated or 
inhibited by the drugs, leading to reduced net uric 
acid production, which in turn is reflected in the 
attenated FRAP level. A previous study has shown 
that anti-cancer drugs are potent xanthine oxidase 
inhibitors (42).
 In conclusion, this study provides evidence 
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that patients with both CRC and parasitic infections 
secrete significant amounts of serum and plasma 
metabolites derived from oxidative stress damage. 
The incidence of parasitic infections in CRC 
patients is high. Parasitic infection and CRC may 
contribute  to oxidative stress independently, but 
when present together, the oxidative stress burden 
imposed by the parasites may be attenuated. 
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